HIV Protective Drugs "Do Not Increase Sexual Risk-Taking"
October 23, 2013
This article was recently reported by Medical News Today.
A new study indicated that individuals in a heterosexual HIV-serodiscordant relationship who were using pre-exposure prophylactic drugs (PrEP) to prevent HIV transmission did not increase sexual risk-taking although they knew they were protected.
The researchers, led by Dr. Jared Baeten of the University of Washington, Seattle, conducted a longitudinal study to determine whether an HIV-uninfected man or woman who was protected from HIV transmission through the use of PrEP would exhibit risky sexual behavior. The researchers analyzed data on more than 3,000 participants in the Partners PrEP study. They conducted the analysis for up to 12 months before the efficacy of PrEP was shown in 2011 and 12 months after when participants knew of its protective effects. Participants also received risk-reduction counseling, safety monitoring, pregnancy testing, and gonorrhea, chlamydia, and trichomoniasis testing.
Findings showed that after being informed of the protective effects of PrEP, participants displayed no significant difference in level of unprotected sex between partners.
Medical News Today
10.17.2013; Honor Whiteman
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)